Patient involvement in selection of immunosuppressive regimen following transplantation

Autor: Popoola J, Greene H, Kyegombe M, MacPhee IA

Publikováno v: Patient Preference and Adherence, Vol 2014, Iss default, Pp 1705-1712 (2014)

Joyce Popoola,1,3 Helen Greene,2 Margaret Kyegombe,2 Iain A MacPhee1,3 1Department of Nephrology and Transplantation, 2Department of Pharmacy, St George’s Healthcare NHS Trust, 3St George’s University of London, London, UK Abstract: Transplantati

Externí odkaz: https://doaj.org/article/9df82db7d0764ccab879e77e3e3fcec7

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

CYP3A5 as a candidate gene for hypertension: no support from an unselected indigenous West African population.

Autor: Fisher DL; Analytical Services International Ltd, St George's, University of London, London, UK., Plange-Rhule J; School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.; Komfo Anokye Teaching Hospital, Kumasi, Ghana., Moreton M; Analytical Services International Ltd, St George's, University of London, London, UK., Eastwood JB; Institute of Medical and Biomedical Education: Renal Medicine, St George's, University of London, London, UK., Kerry SM; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Micah F; Komfo Anokye Teaching Hospital, Kumasi, Ghana., Johnston A; Analytical Services International Ltd, St George's, University of London, London, UK., Cappuccio FP; Division of Mental Health & Wellbeing, University of Warwick, Warwick Medical School, Coventry, UK., MacPhee IA; Institute of Medical and Biomedical Education: Renal Medicine, St George's, University of London, London, UK.

Publikováno v: Journal of human hypertension [J Hum Hypertens] 2016 Dec; Vol. 30 (12), pp. 778-782. Date of Electronic Publication: 2016 Jun 23.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.

Autor: Birdwell KA; Division of Nephrology Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.; Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA., Decker B; Division of Nephrology and Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA., Barbarino JM; Department of Genetics, Stanford University, Stanford, California, USA., Peterson JF; Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.; Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee, USA., Stein CM; Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA., Sadee W; Center for Pharmacogenomics, School of Medicine, The Ohio State University, Columbus, Ohio, USA., Wang D; Center for Pharmacogenomics, School of Medicine, The Ohio State University, Columbus, Ohio, USA., Vinks AA; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA., He Y; Institute of Clinical Pharmacology, Central South University, Changsha, Hunan, Peoples Republic of China., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Leeder JS; Division of Clinical Pharmacology and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Hospitals and Clinics, Kansas City, Missouri, USA., van Schaik R; Department of Clinical Chemistry, Erasmus MC Rotterdam, The Netherlands., Thummel KE; Department of Pharmaceutics, University of Washington, Seattle, Washington, USA., Klein TE; Department of Genetics, Stanford University, Stanford, California, USA., Caudle KE; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., MacPhee IA; Institute of Medical and Biomedical Education, Renal Medicine, St. George's, University of London, London, UK.

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2015 Jul; Vol. 98 (1), pp. 19-24. Date of Electronic Publication: 2015 Jun 03.

HSP70, Peroxiredoxin-3 and -6 are upregulated during renal warm ischaemia in a donation after circulatory death model.

Autor: Hossain MA; Department of Renal Transplantation, St. George's Hospital NHS Trust, Blackshaw Rd., Tooting, London SW17 0QT, United Kingdom. Electronic address: mhossain@nhs.net., De Souza AI; Cardiovascular Sciences Research Centre, Division of Clinical Sciences, St. George's, University of London, Cranmer Terrace, Tooting, London SW17 0RE, United Kingdom., Bagul A; Department of Renal Transplantation, St. George's Hospital NHS Trust, Blackshaw Rd., Tooting, London SW17 0QT, United Kingdom., MacPhee IA; Department of Renal Transplantation, St. George's Hospital NHS Trust, Blackshaw Rd., Tooting, London SW17 0QT, United Kingdom; Division of Clinical Sciences: Renal Medicine, St. George's, University of London, Cranmer Terrace, Tooting, London SW17 0RE, United Kingdom., Kessaris N; Department of Nephrology and Transplantation, Guy's Hospital, Great Maze Pond, London SE1 9RT, United Kingdom., Morsy MA; Department of Renal Transplantation, St. George's Hospital NHS Trust, Blackshaw Rd., Tooting, London SW17 0QT, United Kingdom.

Publikováno v: Journal of proteomics [J Proteomics] 2014 Aug 28; Vol. 108, pp. 133-45. Date of Electronic Publication: 2014 May 24.